AAOI, QURE and VJET among pre-market losers
- uniQure (QURE) -29% announces update on U.S. phase I/II clinical trial of AMT-130 gene therapy for the treatment of huntington’s disease.
- VCI Global Limited (VCIG) -20%.
- Red Cat Holdings (RCAT) -13%.
- voxeljet (VJET) -10%.
- Sonic Foundry (SOFO) -8%.
- First Wave BioPharma (FWBI) -7%.
- CXApp (CXAI) -6%.
- The Beauty Health Company (SKIN) -6%.
- Applied Optoelectronics (AAOI) -5%.
- Coherent (COHR) -5% launches 65W power pump laser diode.
Recommended For You
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.